DOCSLIB.ORG

Endothelial-Specific YY1 Governs Sprouting Angiogenesis Through Directly Interacting with RBPJ

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Endothelial-Specific YY1 Governs Sprouting Angiogenesis Through Directly Interacting with RBPJ Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ Shuya Zhanga,b,1, Ji Young Kima,1,2, Suowen Xua, Huan Liua,b, Meimei Yina, Marina Korolevaa, Jia Guoc, Xiuying Peib, and Zheng Gen Jina,3 aAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642; bKey Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China; and cPulmonary Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 Edited by Napoleone Ferrara, University of California San Diego, La Jolla, CA, and approved January 23, 2020 (received for review September 17, 2019) Angiogenesis, the formation of new blood vessels, is tightly (11, 12). More recently, there has been an increase in the discovery regulated by gene transcriptional programs. Yin Ying 1 (YY1) is a of critical and selective transcriptional factors that mediate the ubiquitously distributed transcription factor with diverse and signaling transduction and regulate multiple aspects of EC behav- complex biological functions; however, little is known about the iors, such as sprouting (13, 14). cell-type-specific role of YY1 in vascular development and angio- Yin Yang 1 (YY1) is a ubiquitously expressed GLI-Krüppel zinc genesis. Here we report that endothelial cell (EC)-specific YY1 de- finger-containing transcription factor (15). It is highly conserved letion in mice led to embryonic lethality as a result of abnormal from Xenopus to human species and contributes to various bi- angiogenesis and vascular defects. Tamoxifen-inducible EC-specific ological processes including cell proliferation, differentiation, and YY1 YY1iΔEC knockout ( ) mice exhibited a scarcity of retinal sprout- development by functioning as a transcriptional repressor or ac- YY1iΔEC ing angiogenesis with fewer endothelial tip cells. mice also tivator in a context-dependent manner (16). Constitutive ablation displayed severe impairment of retinal vessel maturation. In an ex of YY1 in mice leads to early embryonic lethality with a defect of vivo mouse aortic ring assay and a human EC culture system, YY1 egg cylinder formation (17). A small subset of YY1 heterozygote depletion impaired endothelial sprouting and migration. Mecha- embryos is developmentally delayed and exhibits neurulation de- nistically, YY1 functions as a repressor protein of Notch signaling fects, suggesting that YY1 may have additional functions during that controls EC tip-stalk fate determination. YY1 deficiency en- late embryogenesis in mice. YY1 floxed mice showed a critical, hanced Notch-dependent gene expression and reduced tip cell for- mation. Specifically, YY1 bound to the N-terminal domain of RBPJ dose-dependent requirement for YY1 in late embryonic devel- (recombination signal binding protein for Ig Kappa J region) and opment and cell proliferation (18). It has been reported that YY1 competed with the Notch coactivator MAML1 (mastermind-like in tumor cells is implicated in tumor angiogenesis through driving – protein 1) for binding to RBPJ, thereby impairing the NICD (intra- HIF1-dependent expression of VEGF in tumor cells (19 21). cellular domain of the Notch protein)/MAML1/RBPJ complex for- However, the role of endothelial-specific YY1 in vascular devel- mation. Our study reveals an essential role of endothelial YY1 in opment and angiogenesis was unknown. To investigate the role of YY1 in the vascular system, we controlling sprouting angiogenesis through directly interacting ECKO with RBPJ and forming a YY1-RBPJ nuclear repression complex. generated EC-specific YY1-deficient (YY1 ) mice, and we YY1 | endothelial cells | sprouting angiogenesis | RBPJ | transcription factor Significance ngiogenesis represents the formation of new blood vessels Endothelial sprouting is critical for both physiological and Afrom preexisting vessels in a series of morphogenetic events pathological angiogenesis. However, the molecular mecha- that involve vascular sprouting, branching, anastomoses, lumen nisms underlying precise regulation of endothelial sprouting formation, remodeling, maturation, and final establishment of have not been fully understood. Here we show that the tran- the functionally perfused vascular network (1, 2).Vascular sprouting scription factor Yin Ying 1 (YY1) functions as a repressor of is critical for both physiological and pathological angiogenesis. Notch signaling through its inhibition of the intracellular do- Therefore, a deeper understanding of the mechanisms underlying main of the Notch protein/mastermind-like protein 1/recom- vascular sprouting is essential for developing novel therapeutic bination signal binding protein for Ig Kappa J region complex strategies to modulate angiogenesis (3, 4). Tip cells are specialized formation and modulates endothelial cell tip-stalk fate de- endothelial cells (ECs) and are required for sprouting angiogenesis. termination. Our results reveal that YY1 plays an important Tip cells directionally migrate into the avascular area with dynamic role in regulating endothelial sprouting and angiogenesis and actin-based filopodia extension (5). The filopodia are used to sense suggestYY1couldbeapotentialmoleculartargetforangiogenesis- the surroundings for guidance cues and to steer the formation of the related diseases. sprouts in a specific direction. Following tip cells sprouting, endo- Author contributions: S.Z., J.Y.K., X.P., and Z.G.J. designed research; S.Z., J.Y.K., S.X., H.L., thelial stalk cells proliferate to provide the building blocks for M.Y., and M.K. performed research; J.G. contributed new reagents/analytic tools; S.Z., growing sprouts (6, 7). J.Y.K., H.L., and Z.G.J. analyzed data; and S.Z., J.Y.K., S.X., X.P., and Z.G.J. wrote the paper. Transcription factors are essential for the proper development The authors declare no competing interest. and homeostasis of the vascular circulatory system by orchestrating This article is a PNAS Direct Submission. angiogenic gene expression (8, 9). For example, alterations in Notch Published under the PNAS license. signaling and its downstream transcription factors, such as recom- 1S.Z. and J.Y.K. contributed equally to this work. bining binding protein suppressor of hairless (RBPJ, also known as 2Present address: Division of Pharmaceutics & Comprehensive Cancer Center, College of CBF1), lead to severe impairments in vascular development and Pharmacy, The Ohio State University, Columbus, OH 43210. angiogenesis (10). Emerging evidence suggested that the interaction 3To whom correspondence may be addressed. Email: [email protected]. between transcription factors and the combinatorial regulation of This article contains supporting information online at https://www.pnas.org/lookup/suppl/ endothelial gene transcription play a crucial role in the orientation doi:10.1073/pnas.1916198117/-/DCSupplemental. of vascular network formation and maintain endothelial integrity First published February 19, 2020. 4792–4801 | PNAS | March 3, 2020 | vol. 117 | no. 9 www.pnas.org/cgi/doi/10.1073/pnas.1916198117 Downloaded by guest on September 29, 2021 ECKO flox/flox found that YY1 mice died during midgestation from vas- CreERT2; YY1 ) mice (24), a well-established model for cular defects in the yolk sac and embryo, including phenotypic inducible gene knockout in the endothelium specifically. YY1 iΔEC abnormality in sprouting angiogenesis, vascular remodeling, and was explicitly deleted in ECs of YY1 mice from postnatal day morphogenesis. To further delineate the role of endothelial YY1 2 (P2) by injecting 50 mg tamoxifen in peanut oil (Sigma) per in postnatal angiogenesis, we generated tamoxifen-inducible EC- mouse (25) (Fig. 2A), which was confirmed by isolated iΔEC iΔEC iΔEC specific YY1 knockout (YY1 ) mice. We observed that YY1 YY1 lung endothelial cells (Fig. 2B) and dual immunostain- mice exhibited abnormal retinal sprouting angiogenesis. We also ing analysis in retinal tissues (SI Appendix, Fig. S4). Then we found that YY1 depletion impaired endothelial sprouting and performed IB4 staining, which allows us to visualize the retinal iΔEC migration in intact mouse aortic ring ex vivo and in cultured vasculature. At postnatal day 5 (P5), retinas from YY1 mice human ECs in vitro. Mechanistically, we uncovered that YY1 is a showed delayed vessel growth and a hyperpruned vascular net- critical regulator of Notch signaling through directly interacting work that had fewer ECs in the retina compared with those from iΔEC with RBPJ. YY1 was found to be necessary for filopodia for- WT mice (Fig. 2C). Quantitatively, the retinas of YY1 mice mation of endothelial tip cells by regulating Notch-dependent displayed a remarkable decrease in vascular density (Fig. 2D) gene transcription. Collectively, our study reveals a role for YY1 and vessel length (Fig. 2E). Furthermore, endothelial tip cells as a crucial modulator of Notch signaling that mediates both de- were visualized by CD34 staining (26–28). Strikingly, the front iΔEC velopmental and physiological angiogenesis. vascular region of YY1 mice exhibited a blunted-end, aneurysm- like structure with fewer and malformed filopodia compared with iΔEC Results thoseinWTmice(Fig.2F). The endothelial tip cells in YY1 mice EC-Specific YY1 Deletion Leads to Embryonic Lethality Due to Vascular also had defective lumen
Load more

Recommended publications
  • Precision Medicine for Human Cancers with Notch Signaling Dysregulation (Review)
    INTERNATIONAL JOURNAL OF MOleCular meDICine 45: 279-297, 2020 Precision medicine for human cancers with Notch signaling dysregulation (Review) MASUKO KATOH1 and MASARU KATOH2 1M & M PrecMed, Tokyo 113-0033; 2Department of Omics Network, National Cancer Center, Tokyo 104-0045, Japan Received September 16, 2019; Accepted November 20, 2019 DOI: 10.3892/ijmm.2019.4418 Abstract. NOTCH1, NOTCH2, NOTCH3 and NOTCH4 are conjugate (ADC) Rova-T, and DLL3-targeting chimeric antigen transmembrane receptors that transduce juxtacrine signals of receptor‑modified T cells (CAR‑Ts), AMG 119, are promising the delta-like canonical Notch ligand (DLL)1, DLL3, DLL4, anti-cancer therapeutics, as are other ADCs or CAR-Ts targeting jagged canonical Notch ligand (JAG)1 and JAG2. Canonical tumor necrosis factor receptor superfamily member 17, Notch signaling activates the transcription of BMI1 proto-onco- CD19, CD22, CD30, CD79B, CD205, Claudin 18.2, fibro- gene polycomb ring finger, cyclin D1, CD44, cyclin dependent blast growth factor receptor (FGFR)2, FGFR3, receptor-type kinase inhibitor 1A, hes family bHLH transcription factor 1, tyrosine-protein kinase FLT3, HER2, hepatocyte growth factor hes related family bHLH transcription factor with YRPW receptor, NECTIN4, inactive tyrosine-protein kinase 7, inac- motif 1, MYC, NOTCH3, RE1 silencing transcription factor and tive tyrosine-protein kinase transmembrane receptor ROR1 transcription factor 7 in a cellular context-dependent manner, and tumor-associated calcium signal transducer 2. ADCs and while non-canonical Notch signaling activates NF-κB and Rac CAR-Ts could alter the therapeutic framework for refractory family small GTPase 1. Notch signaling is aberrantly activated cancers, especially diffuse-type gastric cancer, ovarian cancer in breast cancer, non-small-cell lung cancer and hematological and pancreatic cancer with peritoneal dissemination.
    [Show full text]
  • TGF-Β1 Signaling Targets Metastasis-Associated Protein 1, a New Effector in Epithelial Cells
    Oncogene (2011) 30, 2230–2241 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE TGF-b1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells SB Pakala1, K Singh1,3, SDN Reddy1, K Ohshiro1, D-Q Li1, L Mishra2 and R Kumar1 1Department of Biochemistry and Molecular Biology and Institute of Coregulator Biology, The George Washington University Medical Center, Washington, DC, USA and 2Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA In spite of a large number of transforming growth factor b1 gene chromatin in response to upstream signals. The (TGF-b1)-regulated genes, the nature of its targets with TGF-b1-signaling is largely mediated by Smad proteins roles in transformation continues to be poorly understood. (Massague et al., 2005) where Smad2 and Smad3 are Here, we discovered that TGF-b1 stimulates transcription phosphorylated by TGF-b1-receptors and associate with of metastasis-associated protein 1 (MTA1), a dual master the common mediator Smad4, which translocates to the coregulator, in epithelial cells, and that MTA1 status is a nucleus to participate in the expression of TGF-b1-target determinant of TGF-b1-induced epithelial-to-mesenchymal genes (Deckers et al., 2006). Previous studies have shown transition (EMT) phenotypes. In addition, we found that that CUTL1, also known as CDP (CCAAT displacement MTA1/polymerase II/activator protein-1 (AP-1) co-activator protein), a target of TGF-b1, is needed for its short-term complex interacts with the FosB-gene chromatin and stimu- effects of TGF-b1 on cell motility involving Smad4- lates its transcription, and FosB in turn, utilizes FosB/histone dependent pathway (Michl et al.,2005).
    [Show full text]
  • Multifactorial Erβ and NOTCH1 Control of Squamous Differentiation and Cancer
    Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer Yang Sui Brooks, … , Karine Lefort, G. Paolo Dotto J Clin Invest. 2014;124(5):2260-2276. https://doi.org/10.1172/JCI72718. Research Article Oncology Downmodulation or loss-of-function mutations of the gene encoding NOTCH1 are associated with dysfunctional squamous cell differentiation and development of squamous cell carcinoma (SCC) in skin and internal organs. While NOTCH1 receptor activation has been well characterized, little is known about how NOTCH1 gene transcription is regulated. Using bioinformatics and functional screening approaches, we identified several regulators of the NOTCH1 gene in keratinocytes, with the transcription factors DLX5 and EGR3 and estrogen receptor β (ERβ) directly controlling its expression in differentiation. DLX5 and ERG3 are required for RNA polymerase II (PolII) recruitment to the NOTCH1 locus, while ERβ controls NOTCH1 transcription through RNA PolII pause release. Expression of several identified NOTCH1 regulators, including ERβ, is frequently compromised in skin, head and neck, and lung SCCs and SCC-derived cell lines. Furthermore, a keratinocyte ERβ–dependent program of gene expression is subverted in SCCs from various body sites, and there are consistent differences in mutation and gene-expression signatures of head and neck and lung SCCs in female versus male patients. Experimentally increased ERβ expression or treatment with ERβ agonists inhibited proliferation of SCC cells and promoted NOTCH1 expression and squamous differentiation both in vitro and in mouse xenotransplants. Our data identify a link between transcriptional control of NOTCH1 expression and the estrogen response in keratinocytes, with implications for differentiation therapy of squamous cancer. Find the latest version: https://jci.me/72718/pdf Research article Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer Yang Sui Brooks,1,2 Paola Ostano,3 Seung-Hee Jo,1,2 Jun Dai,1,2 Spiro Getsios,4 Piotr Dziunycz,5 Günther F.L.
    [Show full text]
  • PGC-1A Protects from Notch-Induced Kidney Fibrosis Development
    BASIC RESEARCH www.jasn.org PGC-1a Protects from Notch-Induced Kidney Fibrosis Development † ‡ ‡ Seung Hyeok Han,* Mei-yan Wu, § Bo Young Nam, Jung Tak Park,* Tae-Hyun Yoo,* ‡ † † † † Shin-Wook Kang,* Jihwan Park, Frank Chinga, Szu-Yuan Li, and Katalin Susztak *Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea; †Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; ‡Severance Biomedical Science Institute, Brain Korea 21 PLUS, Yonsei University College of Medicine, Seoul, Korea; and §Department of Nephrology, The First Hospital of Jilin University, Changchun, China ABSTRACT Kidney fibrosis is the histologic manifestation of CKD. Sustained activation of developmental pathways, such as Notch, in tubule epithelial cells has been shown to have a key role in fibrosis development. The molecular mechanism of Notch-induced fibrosis, however, remains poorly understood. Here, we show that, that expression of peroxisomal proliferation g-coactivator (PGC-1a) and fatty acid oxidation-related genes are lower in mice expressing active Notch1 in tubular epithelial cells (Pax8-rtTA/ICN1) compared to littermate controls. Chromatin immunoprecipitation assays revealed that the Notch target gene Hes1 directly binds to the regulatory region of PGC-1a. Compared with Pax8-rtTA/ICN1 transgenic animals, Pax8-rtTA/ICN1/Ppargc1a transgenic mice showed improvement of renal structural alterations (on his- tology) and molecular defect (expression of profibrotic genes). Overexpression of PGC-1a restored mi- tochondrial content and reversed the fatty acid oxidation defect induced by Notch overexpression in vitro in tubule cells. Furthermore, compared with Pax8-rtTA/ICN1 mice, Pax8-rtTA/ICN1/Ppargc1a mice exhibited improvement in renal fatty acid oxidation gene expression and apoptosis.
    [Show full text]
  • The NOTCH4-HEY1 Pathway Induces Epithelial Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
    Author Manuscript Published OnlineFirst on November 16, 2017; DOI: 10.1158/1078-0432.CCR-17-1366 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. The NOTCH4-HEY1 pathway induces epithelial mesenchymal transition in head and neck squamous cell carcinoma Authors: Takahito Fukusumi1, Theresa W Guo2, Akihiro Sakai1, Mizuo Ando1, Shuling Ren1, Sunny Haft1, Chao Liu1, Panomwat Amornphimoltham1, J. Silvio Gutkind1, Joseph A Califano1 1 Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, MC 0803 La Jolla, California 92093, U.S.A. 2 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, 1550 Orleans Street, Baltimore, Maryland 21231, U.S.A. Running Title: NOTCH4-HEY1 induces EMT in HNSCC Key Words: Head and neck squamous cell carcinoma, TCGA, NOTCH4, HEY1, EMT Financial Support This study was supported by National Institute of Dental and Craniofacial Research (NIDCR, number: R01DE023347). J.A.Califano received this grant. Correspondence: Joseph A. Califano, MD, Department of Otolaryngology - Head and Neck Surgery, University of California San Diego, 3855 Health Science Drive, MC 0803 La Jolla, California 92093, U.S.A. Phone: 619-543-7895; E-mail; [email protected] Disclosure of Potential Conflict of Interest The authors declare no potential conflicts of interest. 1 Downloaded from clincancerres.aacrjournals.org on October 1, 2021. © 2017 American Association for Cancer Research. Author Manuscript Published OnlineFirst on November 16, 2017; DOI: 10.1158/1078-0432.CCR-17-1366 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. ABSTRACT Background: Recently, several comprehensive genomic analyses demonstrated NOTCH1 and NOTCH3 mutations in head and neck squamous cell carcinoma (HNSCC) in approximately 20% of cases.
    [Show full text]
  • Loss of Tgfb Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance Susann Busch1, Andrew H
    Cancer Tumor and Stem Cell Biology Research Loss of TGFb Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance Susann Busch1, Andrew H. Sims2, Olle Sta l3,Ma rten Ferno€4, and Goran€ Landberg1,5 Abstract One third of the patients with estrogen receptor a (ERa)- tamoxifen resistance. Functional investigations confirmed that positive breast cancer who are treated with the antiestrogen cell cycle or apoptosis responses to estrogen or tamoxifen in tamoxifen will either not respond to initial therapy or will ERa-positive breast cancer cells were impaired by TGFBR2 develop drug resistance. Endocrine response involves crosstalk silencing, as was ERa phosphorylation, tamoxifen-induced between ERa and TGFb signaling, such that tamoxifen non- transcriptional activation of TGFb, and upregulation of the responsiveness or resistance in breast cancer might involve multidrug resistance protein ABCG2. Acquisition of low aberrant TGFb signaling. In this study, we analyzed TGFb TGFBR2 expression as a contributing factor to endocrine resis- receptor type 2 (TGFBR2) expression and correlated it with tance was validated prospectively in a tamoxifen-resistant cell ERa status and phosphorylation in a cohort of 564 patients line generated by long-term drug treatment. Collectively, our who had been randomized to tamoxifen or no-adjuvant treat- results established a central contribution of TGFb signaling in ment for invasive breast carcinoma. We also evaluated an endocrineresistanceinbreastcancerandofferedevidencethat additional four independent genetic datasets in invasive breast TGFBR2 can serve as an independent biomarker to predict cancer. In all the cohorts we analyzed, we documented an treatment outcomes in ERa-positive forms of this disease. association of low TGFBR2 protein and mRNA expression with Cancer Res; 75(7); 1457–69.
    [Show full text]
  • I IDENTIFYING GENETIC MECHANISMS of CARDIOMETABOLIC
    IDENTIFYING GENETIC MECHANISMS OF CARDIOMETABOLIC TRAITS AND DISEASES USING QUANTITATIVE SEQUENCE DATA Martin L. Buchkovich A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Curriculum in Bioinformatics and Computational Biology. Chapel Hill 2015 Approved by: Praveen Sethupathy Yun Li Gregory E. Crawford Terrence S. Furey Karen L. Mohlke i ©2015 Martin L. Buchkovich ALL RIGHTS RESERVED ii ABSTRACT Martin L. Buchkovich: Identifying genetic mechanisms of cardiometabolic traits and diseases using quantitative sequence data (Under the direction of Karen L. Mohlke and Terrence S. Furey) Cardiometabolic diseases are a worldwide health concern. Genetics studies have identified hundreds of genetic loci associated with these diseases and other cardiometabolic risk factors, but gaps remain in the understanding of the biological mechanisms responsible for these associations. Sequence data from quantitative experiments, such as DNase-seq and ChIP-seq, that identify genomic regions regulating gene transcription are helping to fill these gaps. Allelic imbalance at heterozygous sites, or enrichment of one allele, in this data can indicate allelic differences in transcriptional regulation, but reference mapping biases present in sequence alignments prevent accurate allelic imbalance detection. We describe a pipeline, AA-ALIGNER, that removes mapping biases at heterozygous sites and increases allelic imbalance detection accuracy in samples with any amount of genotype data available. When complete genotype information is not available, AA-ALIGNER more accurately detects allelic imbalance at imputed heterozygous sites than heterozygous sites predicted using the sequence data. At predicted heterozygous sites, imbalance detection is more accurate at common variants than other variants.
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]
  • HEY1 Functions Are Regulated by Its Phosphorylation at Ser-68
    Biosci. Rep. (2016) / 36 / art:e00343 / doi 10.1042/BSR20160123 HEY1 functions are regulated by its phosphorylation at Ser-68 Irene Lopez-Mateo*,´ Amaia Arruabarrena-Aristorena†, Cristina Artaza-Irigaray‡, Juan A. Lopez´ §, Enrique Calvo§ and Borja Belandia*1 *Department of Cancer Biology, Instituto de Investigaciones Biomedicas´ Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain †Proteomics Unit, CIC bioGUNE, Bizkaia Technology Park, 48160 Derio, Spain ‡Division´ de Inmunolog´ıa, Centro de Investigacion´ Biomedica´ de Occidente – IMSS, Sierra Mojada 800, 44340 Guadalajara, Jalisco, Mexico §Unidad de Proteomica, Centro Nacional de Investigaciones Cardiovasculares, CNIC, 28029 Madrid, Spain Synopsis HEY1 (hairy/enhancer-of-split related with YRPW motif 1) is a member of the basic helix–loop–helix-orange (bHLH-O) family of transcription repressors that mediate Notch signalling. HEY1 acts as a positive regulator of the tumour suppressor p53 via still unknown mechanisms. A MALDI-TOF/TOF MS analysis has uncovered a novel HEY1 regulatory phosphorylation event at Ser-68. Strikingly, this single phosphorylation event controls HEY1 stability and function: simulation of HEY1 Ser-68 phosphorylation increases HEY1 protein stability but inhibits its ability to enhance p53 transcriptional activity. Unlike wild-type HEY1, expression of the phosphomimetic mutant HEY1-S68D failed to induce p53-dependent cell cycle arrest and it did not sensitize U2OS cells to p53-activating chemotherapeutic drugs. We have identified two related kinases, STK38 (serine/threonine kinase 38) and STK38L (serine/threonine kinase 38 like), which interact with and phosphorylate HEY1 at Ser-68. HEY1 is phosphorylated at Ser-68 during mitosis and it accumulates in the centrosomes of mitotic cells, suggesting a possible integration of HEY1-dependent signalling in centrosome function.
    [Show full text]
  • Notch Signaling in Breast Cancer: a Role in Drug Resistance
    cells Review Notch Signaling in Breast Cancer: A Role in Drug Resistance McKenna BeLow 1 and Clodia Osipo 1,2,3,* 1 Integrated Cell Biology Program, Loyola University Chicago, Maywood, IL 60513, USA; [email protected] 2 Department of Cancer Biology, Loyola University Chicago, Maywood, IL 60513, USA 3 Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL 60513, USA * Correspondence: [email protected]; Tel.: +1-708-327-2372 Received: 12 September 2020; Accepted: 28 September 2020; Published: 29 September 2020 Abstract: Breast cancer is a heterogeneous disease that can be subdivided into unique molecular subtypes based on protein expression of the Estrogen Receptor, Progesterone Receptor, and/or the Human Epidermal Growth Factor Receptor 2. Therapeutic approaches are designed to inhibit these overexpressed receptors either by endocrine therapy, targeted therapies, or combinations with cytotoxic chemotherapy. However, a significant percentage of breast cancers are inherently resistant or acquire resistance to therapies, and mechanisms that promote resistance remain poorly understood. Notch signaling is an evolutionarily conserved signaling pathway that regulates cell fate, including survival and self-renewal of stem cells, proliferation, or differentiation. Deregulation of Notch signaling promotes resistance to targeted or cytotoxic therapies by enriching of a small population of resistant cells, referred to as breast cancer stem cells, within the bulk tumor; enhancing stem-like features during the process of de-differentiation of tumor cells; or promoting epithelial to mesenchymal transition. Preclinical studies have shown that targeting the Notch pathway can prevent or reverse resistance through reduction or elimination of breast cancer stem cells. However, Notch inhibitors have yet to be clinically approved for the treatment of breast cancer, mainly due to dose-limiting gastrointestinal toxicity.
    [Show full text]
  • Conditional Deletion of HIF-1Α Provides New Insight
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.16.426940; this version posted January 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Conditional deletion of HIF-1 provides new insight regarding the murine response to gastrointestinal infection with Salmonella Typhimurium Laura Robrahn *, Aline Dupont †, Sandra Jumpertz *, Kaiyi Zhang †, Christian H. Holland ‡ §, Joël Guillaume ¶1, Sabrina Rappold *, Vuk Cerovic ¶, Julio Saez-Rodriguez ‡ §, Mathias W. Hornef † || #, and Thorsten Cramer * ** †† ‡‡ * Department of General, Visceral and Transplantation Surgery, RWTH University Hospital, Pauwelsstraße 30, 52074 Aachen, Germany; † Institute of Medical Microbiology, RWTH University Hospital, Pauwelsstraße 30, 52074 Aachen, Germany; ‡ Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University, and Heidelberg University Hospital, Bioquant, Heidelberg, Germany; § Joint Research Center for Computational Biomedicine, RWTH Aachen University Hospital, Aachen, Germany; ¶ Institute of Molecular Medicine, RWTH University Hospital, Aachen, Germany; ** ESCAM – European Surgery Center Aachen Maastricht, Germany and The Netherlands; †† Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands; ‡‡ NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht,
    [Show full text]
  • HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration S
    University of Kentucky UKnowledge Neuroscience Faculty Publications Neuroscience 5-1-2019 HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration S. Randal Voss University of Kentucky, [email protected] Larissa V. Ponomareva University of Kentucky, [email protected] Varun B. Dwaraka University of Kentucky, [email protected] Kaitlin E. Pardue University of Kentucky Nour W. Al Haj Baddar University of Kentucky, [email protected] See next page for additional authors Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/neurobio_facpub Part of the Anatomy Commons, Cell and Developmental Biology Commons, and the Neuroscience and Neurobiology Commons Repository Citation Voss, S. Randal; Ponomareva, Larissa V.; Dwaraka, Varun B.; Pardue, Kaitlin E.; Al Haj Baddar, Nour W.; Rodgers, A. Katherine; Woodcock, M. Ryan; Qiu, Qingchao; Crowner, Anne; Blichmann, Dana; Khatri, Shivam; and Thorson, Jon S., "HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration" (2019). Neuroscience Faculty Publications. 62. https://uknowledge.uky.edu/neurobio_facpub/62 This Article is brought to you for free and open access by the Neuroscience at UKnowledge. It has been accepted for inclusion in Neuroscience Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Authors S. Randal Voss, Larissa V. Ponomareva, Varun B. Dwaraka, Kaitlin E. Pardue, Nour W. Al Haj Baddar, A. Katherine Rodgers, M. Ryan Woodcock, Qingchao Qiu, Anne Crowner, Dana Blichmann, Shivam Khatri, and Jon S. Thorson HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration Notes/Citation Information Published in Scientific Reports, v.
    [Show full text]